BEIJING, Jan. 20, 2026 /PRNewswire/ -- Beijing Tsingke Biotech Co., Ltd., a leading biotechnology company, today announced ...
Beijing Tsingke Biotech Co., Ltd., a leading biotechnology company, today announced the launch of its redesigned global ...
This model is suitable for investigating viral pathogenic mechanisms, gene function, and virus-host interactions. It can also be used for testing HPV-related vaccines and developing and validating ...
Dublin, Jan. 05, 2026 (GLOBE NEWSWIRE) -- The "Viral Vector Collaboration and Licensing Deals 2016-2025" has been added to ResearchAndMarkets.com's offering. This report contains a comprehensive ...
Viral vectors are a key component of many advanced gene therapies and vaccines, but reliable, large-scale manufacturing remains a significant challenge. Continued innovation in vector design, cell ...
CDMO AGC Biologics signed a licensing agreement for Asimov’s off-the-shelf LV Edge Packaging cell line. AGC Biologics’ Cell and Gene Center of Excellence in Milan now offers a lentiviral packaging ...
Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, and AGC Biologics, your friendly CDMO expert, have signed a licensing agreement for Asimov’s off-the-shelf ...
Jonah Kaplan is an award-winning journalist who has built a strong reputation for his balanced reporting, thoughtful interviews, and deeply researched coverage of high-impact issues affecting the ...
Asimov’s LV Edge Packaging cell line routinely achieves high titers for therapeutic transgenes and is now available at AGC Biologics’ Cell and Gene Center of Excellence BOSTON & MILAN--(BUSINESS WIRE) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results